Ana Rita Pereira Azevedo (251F-01FE-9403)

Curriculum Vitae

Rita Azevedo

Rita Azevedo graduated in Biochemistry from the Instituto Universitário de Ciências of CESPU group in 2012. She started her research pathway in the field of pharmacogenetics by integrating the Molecular Oncology Group & Viral Pathology – Research Centre, Portuguese Institute of Oncology – Porto, for two years. Rita Azevedo completed an MSc in Medical Informatics in 2014 from the Faculty of Medicine of the University of Porto, with a dissertation about mobile health (mHealth) for disease self-management. In 2014 she started her PhD degree in Pathology and Molecular Genetics at the Abel Salazar Biomedical Sciences Institute of the University of Porto aimed to develop novel therapeutic strategies based on glycoproteins in bladder cancer, with funding from a grant from the Foundation for the Science and Technology (FCT) (SFRH/BD/105355/2014). She also joined the Experimental Pathology and Therapeutics Group of the Portuguese Institute of Oncology – Porto, the host institution where the PhD work has been developed. Her thesis has set a roadmap for glycobiomarker discovery in bladder cancer (cell lines, biopsies, and urine samples), exploring the full potential of glycomics, glycoproteomics, and high-resolution mass spectrometry. Moreover, it has set the foundations for glycoepitopes synthesis and purification, providing the necessary structural and clinical rationale for supporting the development of novel glycan-based theranostics applications. In 2020, Rita Azevedo had her first abroad experience and started as a post-doctoral researcher in the Pulliainen-laboratory at the University of Turku, Finland. She was interested in conducting proteomics in Salmonellosis models and exploring ADP-ribosylation using high-resolution mass spectrometry (DDA). In 2021, she moved to France and started as a research engineer in the François Becher group at CEA Saclay, Ille-de-France. She characterized and quantified tau protein in Alzheimer’s disease using high-resolution mass spectrometry (DDA and PRM), aiming to find novel tau proteoforms as biomarkers. At two months before the end of 2022, she joined as a research engineer to Matondo’s Proteomics Platform UTechS Mass Spectrometry for Biology Utechs (MSBio), Institut Pasteur. Rita Azevedo published 31 scientific articles (11 publications as 1st author, 8 reviews; mean journal impact factor of 4.37) with a cumulative journal impact factor of 135, an H-index of 22 (Scopus), and a total citations number of 1,058 (Scopus, Author ID: 55825758200).

Read full resume ↓

Identification

Personal identification

Full name: Ana Rita Pereira Azevedo

Citation names

Azevedo, Rita
Pereira Azevedo, Ana Rita

Author identifiers

Ciência ID: 251F-01FE-9403
ORCID iD: 0000-0002-3015-9675
Scopus Author Id: 55825758200

Websites

https://www.researchgate.net/profile/Rita_Azevedo (Professional)
https://orcid.org/my-orcid?orcid=0000-0002-3015-9675 (Professional)

Knowledge fields

Medical and Health Sciences - Medical Biotechnology - Health-Related Biotechnology
Medical and Health Sciences - Health Sciences

Languages

Language	Speaking	Reading	Writing	Listening	Peer-review
Portuguese (Mother tongue)
English	Proficiency (C2)	Proficiency (C2)	Proficiency (C2)	Proficiency (C2)	Proficiency (C2)
French	Beginner (A1)	Elementary (A2)	Beginner (A1)	Elementary (A2)	Beginner (A1)
Spanish; Castilian	Beginner (A1)	Beginner (A1)	Beginner (A1)	Beginner (A1)	Beginner (A1)

Education

	Degree	Classification
2015 - 2019 Concluded	Patologia e Genética Molecular (Doutoramento) Major in Glycoproteomics and glycomics Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal "Development of monoclonal antibodies for bladder cancer based on glycobiomarkers: identification of relevant glycoantigens and synthesis methodologies thereof" (THESIS/DISSERTATION)	Aprovado
2012 - 2014 Concluded	Informática Médica (Mestrado) Major in mHealth Universidade do Porto Faculdade de Medicina, Portugal "Development of a Smartphone application for Rheumatoid Arthritis self-management" (THESIS/DISSERTATION)	17 valores (em 20 valores)
2009 - 2012 Concluded	Bioquímica (Licenciatura) Major in Pharmacogenetics Instituto Universitário de Ciências da Saúde, Portugal Cooperativa de Ensino Superior Politécnico e Universitário, CESPU, Portugal "Polimorfismos genéticos do Timidilato Sintetase no tratamento da Artrite Reumatoide" (THESIS/DISSERTATION)	15 valores (em 20 valores)

Affiliation

Science

	Category Host institution	Employer
2024/11/01 - Current	Researcher (Research)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
	Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2022/11/02 - 2023/11/30	Contracted Researcher (Research)	Institut Pasteur, France
	Institut Pasteur, France
2021/03/01 - 2022/09/06	Contracted Researcher (Research)	Commissariat a l'energie atomique et aux energies alternatives Centre de Saclay, France

2020/02/01 - 2021/01/31	Postdoc (Research)	Turun yliopisto, Finland

2015/03 - 2019/06/04	Researcher (Research)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

2013/10 - 2014/12	Research Trainee (Research)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

2012/02 - 2012/08	Research Trainee (Research)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Projects

Grant

	Designation	Funders
2015/03 - 2019/03	Development of monoclonal antibodies for chemoresistant bladder cancer based on glycobiomakers SFRH/BD/105355/2014	Fundação para a Ciência e a Tecnologia, I.P.

Outputs

Publications

Conference abstract	Lima, Aurea; Bernardes, Miguel; Azevedo, Rita; Medeiros, Rui; Seabra, Vítor. "Rumo à Medicina Personalizada na Artrite Reumatoide: Polimorfismos no Gene ATIC como Preditores Farmacogenéticos da Resposta Clínica ao Metotrexato". Paper presented in IV Simpósio SPR - Imagiologia, Póvoa do Varzim, 2015. Published Lima, Aurea; Bernardes, Miguel; Azevedo, Rita; Medeiros, Rui; Seabra, Vítor. "Poderão os Polimorfismos no Gene MTHFR Predizer o Perfil de Resposta Clínica ao Metotrexato em Doentes com Artrite Reumatoide?". Paper presented in IV Simpósio SPR - Imagiologia, Póvoa do Varzim, 2015. Published Lima, Aurea; Bernardes, Miguel; Azevedo, Rita; Medeiros, Rui; Seabra, Vítor. "Polimorfismos no ADORA2A como Preditores da Toxicidade ao Metotrexato na Artrite Reumatoide: Um Passo em Direção à Medicina Personalizada". Paper presented in IV Simpósio SPR - Imagiologia, IV Simpósio SPR - Imagiologia, 2015. Published Lima, Aurea; Bernardes, Miguel; Sousa, Hugo; Azevedo, Rita; Medeiros, Rui; Seabra, Vítor. "Prediction of Methotrexate Therapeutic Outcome: Can an Index Risk be more important than a Haplotype approach?". Paper presented in Second ESPT Conference "Pharmacogenomics: From Cell to Clinic", Lisboa, 2014. Published Lima, Aurea; Seabra, Vítor; Bernardes, Miguel; Azevedo, Rita; Sousa, Hugo; Medeiros, Rui. "Role of key TYMS polymorphisms on Methotrexate therapeutic outcome in Rheumatoid Arthritis Portuguese patients". Paper presented in Second ESPT Conference "Pharmacogenomics: From Cell to Clinic", Lisboa, 2014. Published Lima, Aurea; Seabra, Vítor; Bernardes, Miguel; Azevedo, Rita; Sousa, Hugo; Medeiros, Rui. "TYMS polymorphisms and methotrexate therapeutic outcome in rheumatoid arthritis Portuguese patients: analysis of key polymorphisms". Paper presented in European League Against Rheumatism Congress 2014, Paris, 2014. Published Lima, Aurea; Azevedo, Rita; Sousa, Hugo; Bernardes, Miguel; Medeiros, Rui; Seabra, Vítor. "SLC19A1, SLCO1B1 and ABCG2 polymorphisms are associated with Methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients". Paper presented in European League Against Rheumatism Congress 2014, Paris, 2014. Published Lima, Aurea; Bernardes, Miguel; Azevedo, Rita; Sousa, Hugo; Seabra, Vítor; Medeiros, Rui. "SLC22A11 T allele (rs11231809) as a predictor of Methotrexate non-response in Portuguese rheumatoid arthritis patients". Paper presented in XVII Congresso Português de Reumatologia, Algarve, 2014. Published
Conference poster	Relvas-Santos, Marta; Ferreira, Dylan; Peixoto, Andreia; Azevedo, Rita; Freitas, Rui; Miranda, Andreia; Afonso, Luis Pedro; et al. "Glycoengineered Cells and Targeted Glycoproteomics for Immunogenic Glycopeptides Discovery in Bladder Cancer". Paper presented in Glycobiology Gordon Research Seminar: Glycans as Central Players in Biological Processes, 2025. Freitas, Rui; Relvas-Santos, Marta; Pereira Azevedo, Ana Rita ; Soares, Janine; Fernandes, Elisabete; Beatriz Teixeira; Santos, Lúcio; Silva, André M. N.; Ferreira, José Alexandre. Corresponding author: Ferreira, José Alexandre. "Enzymatic synthesis of cancer-associated O-glycopeptides libraries and multivalent protein glycoconjugates: translating synthetic glycoepitopes into cancer glycovaccines". Paper presented in First Summer School in Biomedical Glycoscience, 2022. Peixoto, Andreia; Fernandes, Elisabete; Gaiteiro, Cristiana; Lima, Luís; Azevedo, Rita; Soares, Janine; Cotton, Sofia; et al. "Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation". Paper presented in 29th International Carbohydrate Symposium (ICS 2018) by Peixoto A, 2018.
Journal article	Moona Sakari; Rajendra Bhadane; Sujit Kumar; Rita Azevedo; Morteza Malakoutikhah; Ahmadreza Masoumi; Dene R. Littler; et al. "ADP-ribosyltransferase-based biocatalysis of nonhydrolyzable NAD+ analogs". Journal of Biological Chemistry (2025): https://doi.org/10.1016/j.jbc.2024.108106. 10.1016/j.jbc.2024.108106 Ferreira E; Ferreira D; Relvas-Santos M; Freitas R; Soares J; Azevedo R; Afonso LP; et al. "Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer.". International journal of molecular sciences (2024): http://europepmc.org/abstract/med/38542435. 10.3390/ijms25063462 Jacquemin C; Villain N; Azevedo R; Boluda S; Thévenot EA; Fenaille F; Lamari F; Becher F. "Evaluation of SP3 for antibody-free quantification of tau in CSF mimic and brain by mass spectrometry.". European journal of mass spectrometry (Chichester, England) (2024): http://europepmc.org/abstract/med/38258392. 10.1177/14690667231218912 "Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications". Cells 11 8 (2022): 1279-1279. http://dx.doi.org/10.3390/cells11081279. 10.3390/cells11081279 Gaiteiro, Cristiana; Soares, Janine; Relvas-Santos, Marta; Peixoto, Andreia; Ferreira, Dylan; Paulo, Paula; Brandão, Andreia; et al. "Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion". Theranostics 12 7 (2022): 3150-3177. http://dx.doi.org/10.7150/thno.67409. 10.7150/thno.67409 Peixoto A; Ferreira D; Azevedo R; Freitas R; Fernandes E; Relvas-Santos M; Gaiteiro C; et al. "Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer.". Journal of experimental & clinical cancer research : CR (2021): http://europepmc.org/abstract/med/34108014. 10.1186/s13046-021-01988-6 Sofia Cotton; Dylan Ferreira; Janine Soares; Andreia Peixoto; Marta Relvas-Santos; Rita Azevedo; Paulina Piairo; et al. "Target Score—A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness". International Journal of Molecular Sciences 22 4 (2021): 1664-1664. https://doi.org/10.3390/ijms22041664. 10.3390/ijms22041664 Freitas, R.; Relvas-Santos, M.; Azevedo, R.; Soares, J.; Fernandes, E.; Teixeira, B.; Santos, L.L.; et al. "Single-pot enzymatic synthesis of cancer-associated MUC16: O -glycopeptide libraries and multivalent protein glycoconjugates: A step towards cancer glycovaccines". New Journal of Chemistry 45 20 (2021): 9197-9211. http://www.scopus.com/inward/record.url?eid=2-s2.0-85106745147&partnerID=MN8TOARS. 10.1039/d0nj06021f Elisabete Fernandes; Rui Freitas; Dylan Ferreira; Janine Soares; Rita Azevedo; Cristiana Gaiteiro; Andreia Peixoto; et al. "Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells". Cancers (2020): https://doi.org/10.3390/cancers12040861. 10.3390/cancers12040861 Peixoto A; Relvas-Santos M; Azevedo R; Santos LL; Ferreira JA. "Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks.". Frontiers in oncology (2019): http://europepmc.org/abstract/med/31157165. 10.3389/fonc.2019.00380 Manuel Neves; Rita Azevedo; Luís Lima; Marta I. Oliveira; Andreia Peixoto; Dylan Ferreira; Janine Soares; et al. "Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications". New Biotechnology 49 (2019): 77-87. https://doi.org/10.1016/j.nbt.2018.09.004. 10.1016/j.nbt.2018.09.004 Azevedo R; Soares J; Gaiteiro C; Peixoto A; Lima L; Ferreira D; Relvas-Santos M; et al. "Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.". Talanta (2018): http://europepmc.org/abstract/med/29674052. 10.1016/j.talanta.2018.03.028 Azevedo R; Gaiteiro C; Peixoto A; Relvas-Santos M; Lima L; Santos LL; Ferreira JA. "CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications.". Clinical proteomics (2018): http://europepmc.org/abstract/med/29983670. 10.1186/s12014-018-9198-9 Rita Azevedo; Janine Soares; Andreia Peixoto; Sofia Cotton; Luís Lima; Lúcio Lara Santos; José Alexandre Ferreira. "Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology". Urologic Oncology: Seminars and Original Investigations 36 5 (2018): 221-236. https://doi.org/10.1016/j.urolonc.2018.02.004. 10.1016/j.urolonc.2018.02.004 Carrascal MA; Silva M; Ferreira JA; Azevedo R; Ferreira D; Silva AMN; Ligeiro D; et al. "A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer.". Biochimica et biophysica acta (2018): http://europepmc.org/abstract/med/29777742. 10.1016/j.bbagen.2018.05.013 Rita Azevedo; André M.N. Silva; Celso A. Reis; Lúcio Lara Santos; José Alexandre Ferreira. "In silico approaches for unveiling novel glycobiomarkers in cancer". Journal of Proteomics 171 (2018): 95-106. https://doi.org/10.1016/j.jprot.2017.08.004. 10.1016/j.jprot.2017.08.004 Luís Lima; Manuel Neves; Marta I. Oliveira; Lorena Dieguez; Rui Freitas; Rita Azevedo; Cristiana Gaiteiro; et al. "Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases". Urologic Oncology: Seminars and Original Investigations 35 12 (2017): 675.e1-675.e8. https://doi.org/10.1016/j.urolonc.2017.08.012. 10.1016/j.urolonc.2017.08.012 Azevedo, Rita. "Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?". Oncotarget (2017): 10.18632/oncotarget.19433 Cotton S; Azevedo R; Gaiteiro C; Ferreira D; Lima L; Peixoto A; Fernandes E; et al. "Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced stage bladder tumours.". (2017): http://europepmc.org/abstract/med/28156048. 10.1002/1878-0261.12035 Peixoto, A.; Fernandes, E.; Gaiteiro, C.; Lima, L.; Azevedo, R.; Soares, J.; Cotton, S.; et al. "Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension". Oncotarget 7 39 (2016): 63138-63157. http://www.scopus.com/inward/record.url?eid=2-s2.0-84994050563&partnerID=MN8TOARS. 10.18632/oncotarget.11257 Lima, A.; Bernardes, M.; Azevedo, R.; Seabra, V.; Medeiros, R.; Lima A; Bernardes M; et al. "Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome". Pharmacogenomics 17 15 (2016): 1649-1674. http://www.scopus.com/inward/record.url?eid=2-s2.0-84991251048&partnerID=MN8TOARS. 10.2217/pgs-2016-0067 Azevedo R; Ferreira JA; Peixoto A; Neves M; Sousa N; Lima A; Santos LL. "Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review.". (2015): http://europepmc.org/abstract/med/26196222. 10.1016/j.jconrel.2015.07.002 Azevedo, Rita; Bernardes, Miguel; Fonseca, João; Lima, Aurea. "Smartphone application for rheumatoid arthritis self-management: cross-sectional study revealed the usefulness, willingness to use and patients’ needs". Rheumatology International 1 (2015): 1-11. http://link.springer.com/article/10.1007%2Fs00296-015-3270-9. Published • 10.1007/s00296-015-3270-9 Azevedo, Rita; Sousa, Hugo; Monteiro, Joaquim; Lima, Aurea. "Future perspectives of Smartphone applications for rheumatic diseases self-management". Rheumatology International 35 3 (2015): 419-431. http://link.springer.com/article/10.1007%2Fs00296-014-3117-9. Published • 10.1007/s00296-014-3117-9 Lima A; Bernardes M; Azevedo R; Medeiros R; Seabra V. "Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?". (2015): http://europepmc.org/abstract/med/26086825. 10.3390/ijms160613760 Lima A; Sousa H; Monteiro J; Azevedo R; Medeiros R; Seabra V; Lima, Aurea; et al. "Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers.". Pharmacogenomics 15 12 (2014): 1611-1635. http://europepmc.org/abstract/med/25340735. Published • 10.2217/pgs.14.116 Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V. "SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms As Predictors Of Methotrexate-Related Toxicity In Portuguese Rheumatoid Arthritis Patients.". (2014): http://europepmc.org/abstract/med/25124723. 10.1093/toxsci/kfu162 Lima, Aurea; Monteiro, Joaquim; Bernardes, Miguel; Sousa, Hugo; Azevedo, Rita; Seabra, Vítor; Medeiros, Rui. "Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: Implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms". BioMed Research International 2014 368681 (2014): 1-14. Published • 10.1155/2014/368681 Lima, Aurea; Bernardes, Miguel; Sousa, Hugo; Azevedo, Rita; Costa, Lúcia; Ventura, Francisco; Seabra, Vítor; Medeiros, Rui. "SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients". Pharmacogenomics 15 6 (2014): 807-820. Published • 10.2217/pgs.13.244 Lima A; Seabra V; Bernardes M; Azevedo R; Sousa H; Medeiros R. "Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients.". (2014): http://europepmc.org/abstract/med/25279663. 10.1371/journal.pone.0108165 Lima, Aurea; Azevedo, Rita; Sousa, Hugo; Seabra, Vítor; Medeiros, Rui. "Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics". Pharmacogenomics 14 11 (2013): 1337-1413. Published • 10.2217/pgs.13.118

Activities

Oral presentation

	Presentation title	Event name Host (Event location)
2018/06/16	CD44-glycoprofilling: Estabilishing the molecular basis for targeted therapeutics in bladder cancer	29th International Carbohydrate Symposium – ICS2018 Faculdade de Ciências da Universidade de Lisboa (Lisboa, Portugal)
2017/09/12	Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced stage bladder tumours	12ª Reunião do Grupo de Glúcidos – GLUPOR12 Universidade de Aveiro (Aveiro, Portugal)

Event participation

	Activity description Type of event	Event name Institution / Organization
2023/06/20 - 2023/06/23	ProteoAix 2023, the 3rd Joint Meeting of Spanish, French, and Portuguese Proteomics Societies. Aix en Provence, France. Congress	ProteoAix 2023
2022/08/29 - 2022/09/02	Poster communication - Integrated Mass Spectrometry-based Pipeline for Characterization of Tau in Human Alzheimer’s Brain: Development and Comparison of Sample Preparation Methods. International Mass Spectrometry Conference Annual General Meeting 2022 (IMSC22). Congress	International Mass Spectrometry Conference Annual General Meeting 2022
2022/07/31 - 2022/08/04	Poster communication - Integrated Mass Spectrometry-based Pipeline for Characterization of Tau in Human Alzheimer’s Brain: Development and Comparison of Sample Preparation Methods. Alzheimer's Association International Conference 2022 (AAIC22). Congress	Alzheimer's Association International Conference 2022 Alzheimer's Association, United States
2021/11/08 - 2021/11/19	HUPO ReCONNECT 2021 Congress with pre-congress training course and bioinformatics hub. Virtual. Congress	HUPO ReCONNECT 2021 Congress Human Proteome Organisation, Canada
2021/05/18 - 2021/05/19	31st HUPO Human Brain Proteome Project Workshop. Virtual workshop in Neuroproteomics. Workshop	31st HUPO Human Brain Proteome Project Workshop Human Proteome Organisation, Canada
2016/04/28 - 2016/04/28	Poster communication - Emerging Antibody-Based Therapeutic Strategies For Bladder Cancer: A Systematic Review. 2nd ASPIC International Congress. (IPO-Porto Auditorium, Portugal). Congress	2nd ASPIC International Congress Associação Portuguesa de Investigação em Cancro, Portugal
2016/04/07 - 2016/04/09	Poster communication - Antibody-Based Therapeutic Strategies In Clinical Phase Trials For Bladder Cancer: A Systematic Review. Encontros da Primavera – Oncology Spring Meeting 2016 (Évora Hotel, Portugal). Meeting	Encontros da Primavera – Oncology Spring Meeting 2016
2014/05/22 - 2014/05/23	Guest Speaker of the theme “Geração ‘Smartphones’”. XV Scientific Conference of Pharmaceutical Sciences, Higher Institute of Health Sciences - North (ISCS-N), “Estratégias terapêuticas personalizadas”. Organization: Student association of ISCS-N. Exponor. Meeting	XV Scientific Conference of Pharmaceutical Sciences Instituto Universitário de Ciências da Saúde, Portugal

Ad Hoc journal article review

	Journal title (ISSN)	Publisher
2024 - 2024	Gene
2016 - 2016	Rheumatology International

Association member

	Society Organization name	Role
2023/01/01 - Current	Rede ProcuraOmics (Sociedade Portuguesa de Proteomica)	Member
2022/11/01 - Current	American Chemical Society (ACS)	Member
2017/09/01 - Current	Portuguese Association of Chemistry (Sociedade Portuguesa de Química)	Member
2016/02/01 - Current	European Association for Cancer Research (EACR)	Member
2016/02/01 - Current	Portuguese Association for Cancer Research (Associação Portuguesa de Investigação em Cancro – ASPIC)	Member
2023/01/01 - 2023/12/31	Société Française de Spectrométrie de Masse (SFSM)	Member
2021/01/01 - 2022/01/31	American Society for Biochemistry and Molecular Biology (ASBMB)	Member

Course / Discipline taught

	Academic session	Degree Subject (Type)	Institution / Organization
2016/03/10 - 2016/03/10	Theoretical and Practical Course of Molecular Biology Applied to Oncology	1st Precision Oncology Meeting - Porto – “From basic research to clinical practice”	Universidade Fernando Pessoa, Portugal

Distinctions

Award

2013	Best student 2011-2012 of Degree in Biochemistry at ISCS-N Cooperativa de Ensino Superior Politécnico e Universitário, CESPU, Portugal